Clinical Trial Update: TIPS Combined With Lenvatinib and PD-1 Inhibitor for Advanced HCC With Main Trunk PVTT [NA]

View source ↗

Summary

Clinical trial update describing a study of combining transjugular intrahepatic portosystemic shunt (TIPS) with lenvatinib and a PD-1 inhibitor for advanced hep…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Portal Vein Tumor Thrombus

Drugs mentioned

• Lenvatinib (lenvatinib)
• PD-1 inhibitor

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma, Portal Vein Tumor Thrombus | NA | Status: RECRUITING